Company
Drugs for Neglected Diseases Initiative
DNDi is an international not-for-profit research and development organization that discovers, develops, and delivers treatments for neglected diseases.
Drugs for Neglected Diseases Initiative is a privately held company, based in Switzerland. Leadership tracked by CEOInsider includes Bernard Pécoul (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on the Drugs for Neglected Diseases Initiative's leadership transition, with founder Bernard Pécoul stepping down after 19 years leading the organization. The headlines also reflect the organization's ongoing work developing and delivering treatments for neglected tropical diseases affecting vulnerable populations, supported by grants from major foundations and pharmaceutical companies, as well as its broader mission to provide affordable medicines outside traditional pricing models.
Summarized from the headlines in the sidebar; see each source for the full story.